psilocybin

Havn Life Sciences Ivan Casselman Casselman

Havn Life Sciences chief psychedelic officer marries love of plants with desire to help

Dr. Ivan Casselman says he has been setting himself up to work in the psychedelic industry for quite some time.

0
ptsd-psilocin

Enhancer boosts psilocin potential in psychedelic therapy to treat PTSD

Canadian company NeuroPharm Inc. files application with the U.S. Patent and Trademark Office in connection with a psychedelic therapy.

0
PTSD

MDMA shows potential in PTSD treatment; more research needed on other psychedelics

Australian researchers review the state of the evidence for using these drugs in the treatment of post-traumatic stress disorder

0
Berkeley-shrooms

UC Berkeley is launching a new centre for psychedelic research

The centre’s cofounders include UC Berkeley neuroscientist David Presti, psychologist Dacher Keltner, and journalism professor Michael Pollan

0
Havn Life psychedelics company

Vancouver psychedelics company Havn Life obtains Health Canada exemption

Health Minister Patty Hajdu has given its wholly owned subsidiary the green light to possess pure psilocybin for research purposes.

0
MAPS Canada psychedelic medicines

MAPS Canada advances understanding about psychedelic medicines

For the past decade, executive director Mark Haden has been educating physicians on how these molecules could help patients with posttraumatic stress disorder, treatment-resistant depression, and other conditions

0
psychedelics-research

NDP health critic Don Davies backs psychedelics research

Health Canada allows certain companies to conduct research on drugs

0
psilocybin-access

Palliative patients await August 4 Canadian government decision on psilocybin access

Four patients battling cancer seek psilocybin-assisted psychotherapy

0
Mike-Pond

Criminalization of psychedelics holding back promise of healing: therapist Michael Pond

West Vancouver counsellor says psychedelics need to be handled by trained and experienced professionals

0